Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 451โ€“465 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1551
Glucose-6-Phosphate Dehydrogenase (G6PD) Full Length Gene Sequence Analysis Test

This test sequences the entire G6PD gene to identify pathogenic variants causing enzyme deficiency.

Peripheral Whole Blood, Amniotic Fluid, or Cord Blood 2โ€“3 weeks 5,000.00 AED
View
View test specifications and preparation
What it measures
["G6PD gene sequence", "Pathogenic variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions"]
Indications
["Individuals with a family history of G6PD deficiency", "Unexplained hemolytic episodes", "Neonatal jaundice", "Individuals of African, Mediterranean, or Southeast Asian descent", "Prenatal testing for at-risk pregnancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21626-1 ICD-10: D55.0, Z13.79
Clinical summary
This test sequences the entire G6PD gene to identify pathogenic variants causing enzyme deficiency.
TEST-6177
GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 Genetic Test

This genetic test identifies pathogenic variants in the GLUD1 gene associated with congenital hyperinsulinism-hyperammonemia syndrome.

Peripheral Whole Blood 3 โ€“ 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLUD1 gene", "Genetic predisposition to hyperinsulinemic hypoglycemia type 6"]
Parameters
[]
Preparation
["No specific fasting required", "Continue all prescribed medications unless advised otherwise by physician"]
Indications
["Diagnosis of congenital hyperinsulinism-hyperammonemia syndrome", "Family screening for GLUD1 mutations", "Differentiation of persistent hypoglycemia causes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82203-5 ICD-10: E16.1
Clinical summary
This genetic test identifies pathogenic variants in the GLUD1 gene associated with congenital hyperinsulinism-hyperammonemia syndrome.
TEST-6344
GLUL Gene Glutamine Deficiency, Congenital Test

This genetic test identifies mutations in the GLUL gene responsible for congenital glutamine synthetase deficiency.

Peripheral Blood (Whole Blood โ€“ EDTA) 15โ€“21 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLUL gene", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No specific fasting required", "Consult physician regarding medication adjustments"]
Indications
["Diagnosis of suspected congenital glutamine synthetase deficiency", "Carrier testing in at-risk family members", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88990-2 ICD-10: E72.24
Clinical summary
This genetic test identifies mutations in the GLUL gene responsible for congenital glutamine synthetase deficiency.
TEST-6313
GLYCTK Gene D-Glyceric Aciduria Genetic Test

This genetic test analyzes the GLYCTK gene to detect pathogenic variants associated with D-glyceric aciduria.

Peripheral Whole Blood (3โ€“5 mL EDTA) or FTA card (finger-prick dried blood spot) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLYCTK gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Suspected D-glyceric aciduria", "Family history of D-glyceric aciduria", "Neurological deterioration in infants/children"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 68527-6 ICD-10: E72.8
Clinical summary
This genetic test analyzes the GLYCTK gene to detect pathogenic variants associated with D-glyceric aciduria.
TEST-1338
GM2 Gangliosidosis Quantitative Blood Test (Tay-Sachs & Sandhoff Disease)

This diagnostic test evaluates the activity levels of hexosaminidase A and total hexosaminidase enzymes in whole blood.

Whole Blood 4 Working Days 550.00 AED
View
View test specifications and preparation
What it measures
["Hexosaminidase A enzyme activity", "Total hexosaminidase enzyme activity"]
Parameters
[{"name": "Hexosaminidase A", "reference_range": null}, {"name": "Total Hexosaminidase", "reference_range": null}]
Preparation
["No specific fasting required", "Maintain all prescribed medications"]
Indications
["Symptomatic infants and children with suspected GM2 gangliosidosis", "Carrier testing for at-risk couples", "Pre-symptomatic testing", "Confirmation following newborn screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 24066-2 ICD-10: E75.00, E75.01, E75.02, Z14.8
Clinical summary
This diagnostic test evaluates the activity levels of hexosaminidase A and total hexosaminidase enzymes in whole blood.
TEST-3988
GNA13 Genetic Testing for Vascular System Defects Test

This test detects pathogenic variants in the GNA13 gene associated with congenital vascular malformations and related circulatory defects.

Whole blood, FTA card, or previously extracted DNA 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNA13 gene"]
Parameters
[]
Preparation
["No fasting or special preparation required"]
Indications
["Family history of vascular malformations or aneurysms", "Clinical suspicion of GNA13-related vascular disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101581-3 ICD-10: Q27.8, Z13.79, Z84.89
Clinical summary
This test detects pathogenic variants in the GNA13 gene associated with congenital vascular malformations and related circulatory defects.
TEST-3094
GNAI3 Gene Auriculocondylar Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the GNAI3 gene associated with Autosomal Dominant Auriculocondylar Syndrome Type 1 (ACS1).

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GNAI3 gene pathogenic variants", "Copy Number Variations (CNV) in GNAI3"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Auriculocondylar Syndrome Type 1 (ACS1)", "Family members of a confirmed proband for cascade testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81221-0 ICD-10: Q18.8
Clinical summary
This test identifies pathogenic variants in the GNAI3 gene associated with Autosomal Dominant Auriculocondylar Syndrome Type 1 (ACS1).
TEST-4551
GNE Gene Inclusion Body Myopathy Genetic Test

This test evaluates the GNE gene for pathogenic variants associated with GNE Myopathy (Nonaka Myopathy), a hereditary neuromuscular disorder.

Whole Blood (EDTA tube) or Dried Blood Spot (FTA card) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNE gene", "Single-nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Splice-Site Variants"]
Parameters
[{"name": "Diagnostic Precision", "reference_range": ">99.9% โ€” Full gene coverage with 100x mean depth"}, {"name": "Methodology", "reference_range": "NGS (Next Generation Sequencing) + Orthogonal Sanger Confirmation"}, {"name": "Variant Detection", "reference_range": "SNVs, Indels, Splice-Site Variants โ€” Full Coding Region"}]
Preparation
["No fasting required", "Continue all prescribed medications unless instructed otherwise by your neurologist"]
Indications
["Clinical suspicion of GNE Myopathy (Nonaka Myopathy)", "Family history of GNE Myopathy", "Differential diagnosis of hereditary myopathies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-7 ICD-10: G71.0
Clinical summary
This test evaluates the GNE gene for pathogenic variants associated with GNE Myopathy (Nonaka Myopathy), a hereditary neuromuscular disorder.
TEST-6001
GNPTG Gene Mucolipidosis Type III Gamma Genetic Test

This test detects pathogenic variants in the GNPTG gene associated with mucolipidosis type III gamma (pseudo-Hurler polydystrophy). It provides a definitive molecular diagnosis.

Peripheral whole blood (EDTA), extracted DNA, or dried blood spot on DNA FTA card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNPTG gene", "Full gene coverage including coding exons and flanking intronic regions"]
Parameters
[{"name": "Sensitivity", "reference_range": "99.9%"}, {"name": "Gene Coverage", "reference_range": "Full GNPTG gene coverage"}]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Patients with clinical features suggestive of mucolipidosis type III gamma", "Carrier screening", "Prenatal testing", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 87436-6 ICD-10: E77.0
Clinical summary
This test detects pathogenic variants in the GNPTG gene associated with mucolipidosis type III gamma (pseudo-Hurler polydystrophy). It provides a definitive molecular diagnosis.
TEST-3714
GNRHR Gene Hypogonadotropic Hypogonadism Type 7 with or without Anosmia Genetic Test

This genetic test detects pathogenic variants in the GNRHR gene associated with hypogonadotropic hypogonadism type 7.

Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNRHR gene", "Single nucleotide variants", "Small insertions or deletions"]
Parameters
[]
Preparation
["No fasting required", "Genetic counseling session mandatory prior to testing"]
Indications
["Diagnosis of hypogonadotropic hypogonadism type 7", "Family cascade screening", "Fertility planning", "Confirmation of clinical suspicion"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82378-6 ICD-10: E23.0, R41.0
Clinical summary
This genetic test detects pathogenic variants in the GNRHR gene associated with hypogonadotropic hypogonadism type 7.
TEST-5935
GNS Gene Mucopolysaccharidosis Type 3D (MPS 3D) Genetic Test

This test evaluates the GNS gene for pathogenic variants associated with Sanfilippo syndrome type D (MPS 3D). It identifies mutations causing this progressive lysosomal storage dis...

Whole blood (EDTA), extracted DNA, or FTA blood spot 3 to 4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNS gene", "Single nucleotide variants", "Small indels", "Copy number changes"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Individuals with clinical suspicion of Sanfilippo syndrome type D", "Family history of MPS 3D", "Carrier screening in families with affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82373-7 ICD-10: E76.22, Z14.8, Z82.79
Clinical summary
This test evaluates the GNS gene for pathogenic variants associated with Sanfilippo syndrome type D (MPS 3D). It identifies mutations causing this progressive lysosomal storage disorder.
TEST-5689
GPC3 Gene Simpson-Golabi-Behmel Syndrome Type 1 Genetic Test

This test evaluates the GPC3 gene for pathogenic variants associated with Simpson-Golabi-Behmel syndrome type 1.

Peripheral blood (Whole blood in EDTA tube) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GPC3 gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist about anticoagulant medications"]
Indications
["Suspected Simpson-Golabi-Behmel syndrome type 1", "Family history of Simpson-Golabi-Behmel syndrome type 1", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90900-1 ICD-10: Q87.89
Clinical summary
This test evaluates the GPC3 gene for pathogenic variants associated with Simpson-Golabi-Behmel syndrome type 1.
TEST-6228
GPI Gene Hemolytic Anemia, Nonspherocytic, Due to Glucose Phosphate Isomerase Deficiency Genetic Test

This test identifies pathogenic variants in the GPI gene associated with glucose phosphate isomerase deficiency, a cause of chronic nonspherocytic hemolytic anemia.

Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GPI gene", "Exon-level copy number variants"]
Parameters
[]
Preparation
["No special preparation like fasting is required", "Pre-test genetic counseling session recommended"]
Indications
["Diagnosis of glucose phosphate isomerase deficiency", "Differentiation from other enzymopathies", "Family planning and genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: D55.8
Clinical summary
This test identifies pathogenic variants in the GPI gene associated with glucose phosphate isomerase deficiency, a cause of chronic nonspherocytic hemolytic anemia.
TEST-1918
GREM1 Gene Polyposis Syndrome, Hereditary Mixed Genetic Test

This molecular diagnostic assay detects germline mutations in the GREM1 gene associated with hereditary mixed polyposis syndrome (HMPS) and elevated colorectal cancer risk.

Whole Blood (EDTA) or Saliva (Oragene DNA collection kit) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GREM1 gene mutations", "Pathogenic variants", "Deletions", "Duplications"]
Parameters
[]
Preparation
["No special preparation required", "Provide a complete three-generation family history of colorectal cancer and polyposis"]
Indications
["Individuals with a personal or family history suggestive of hereditary colorectal cancer syndromes", "Risk stratification for colorectal cancer"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93940-4 ICD-10: Z15.09
Clinical summary
This molecular diagnostic assay detects germline mutations in the GREM1 gene associated with hereditary mixed polyposis syndrome (HMPS) and elevated colorectal cancer risk.
TEST-5579
GRID2 Gene Schizophrenia Genetic Test

This test evaluates the GRID2 gene for pathogenic variants associated with an increased risk of developing schizophrenia.

Peripheral whole blood, extracted DNA, or dried blood spot (FTA card) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GRID2 gene", "Glutamatergic signaling pathway integrity"]
Parameters
[]
Preparation
[]
Indications
["Risk assessment for schizophrenia susceptibility", "Genetic counseling for individuals with family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103204-6 ICD-10: F20.9
Clinical summary
This test evaluates the GRID2 gene for pathogenic variants associated with an increased risk of developing schizophrenia.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area